Products
Calendar
Audience
Events
Contact
A new way to advertise on our platform
Products
Calendar
Audience
Events
Contact

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

How Timely, Precise Lab Data Drive Decisions from Discovery to Post-Marketing Surveillance

epocrates and DeepIntent Announce First-to-Market Partnership for Programmatic Access Across Point-of-Care Advertising

Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals

Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume

The state of consumer health

Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm

Eliminating KRAS: Why targeted protein degraders could redefine what’s possible in cancer

Medical Affairs: From Proving Activity to Demonstrating Impact

Meet Clicklinks: The Innovation Hub for Original Drug Discovery

With China's growing dominance in the biopharma R&D sector, a collection of g | A group of over 20 global pharma leaders met with…

Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching…

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S. | The program looks to support…

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings…

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…

epocrates and DeepIntent Announce First-to-Market Partnership for Programmatic Access Across Point-of-Care Advertising